BioNTech SE (ETR:22UA)

BioNTech SE Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 22, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	22,789	19,497	26,387	22,698	34,159	54,749
Market Cap Growth	19.57%	-26.11%	16.25%	-33.55%	-37.61%	241.19%
Enterprise Value	9,284	5,224	8,649	7,810	22,089	52,601
Last Close Price	91.45	81.35	108.70	95.02	143.00	212.24
PE Ratio	-	-	-	24.40	3.62	5.32
PS Ratio	7.94	6.79	9.59	5.94	1.97	2.89
PB Ratio	1.19	1.01	1.36	1.12	1.70	4.60
P/TBV Ratio	1.32	1.13	1.45	1.19	1.72	4.68
P/FCF Ratio	81.13	69.41	-	4.43	2.58	71.83
P/OCF Ratio	49.98	42.76	127.04	4.23	2.52	61.54
EV/Sales Ratio	3.23	1.82	3.14	2.05	1.28	2.77
EV/EBITDA Ratio	-	-	-	7.04	1.84	3.53
EV/EBIT Ratio	-	-	-	8.04	1.85	3.54
EV/FCF Ratio	33.05	18.60	-	1.53	1.67	69.01
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.03
Debt / EBITDA Ratio	-	-	-	0.19	0.02	0.02
Debt / FCF Ratio	0.95	0.95	-	0.04	0.02	0.40
Net Debt / Equity Ratio	-0.70	-0.70	-0.80	-0.81	-0.69	-0.15
Net Debt / EBITDA Ratio	11.99	11.99	13.27	-14.71	-1.16	-0.12
Net Debt / FCF Ratio	-47.96	-47.96	197.84	-3.19	-1.05	-2.33
Asset Turnover	0.13	0.13	0.12	0.17	0.89	2.09
Inventory Turnover	3.10	3.10	1.69	1.51	6.36	10.28
Quick Ratio	6.87	6.87	6.88	9.12	7.19	4.15
Current Ratio	7.54	7.54	7.45	9.43	7.43	4.33
Return on Equity (ROE)	-5.88%	-5.88%	-3.36%	4.62%	59.06%	155.18%
Return on Assets (ROA)	-3.56%	-3.56%	-3.53%	2.62%	38.09%	102.25%
Return on Invested Capital (ROIC)	-25.47%	-26.47%	-33.23%	15.07%	106.34%	195.58%
Return on Capital Employed (ROCE)	-6.40%	-6.40%	-6.40%	4.60%	58.60%	120.20%
Earnings Yield	-4.99%	-5.83%	-2.52%	4.10%	27.62%	18.80%
FCF Yield	1.23%	1.44%	-0.30%	22.56%	38.78%	1.39%
Buyback Yield / Dilution	-0.54%	-0.54%	0.95%	2.84%	3.81%	-4.51%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.